Active Ingredient:
HOMEOPATHIC DILUTION OF HPUS Hamamelis Virginiana 200ck **C, K, CK, AND X ARE HOMEOPATHIC DILUTIONS
Hamamelis Virginiana Pellet
FDA Label NDC 76472-3015
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sevene Usa for the product Hamamelis Virginiana (NDC 76472-3015). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient:, traditionally used for:, directions:, use:, warnings:, otc - pregnancy or breast feeding, otc - keep out of reach of children, other information:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Traditionally Used For:
Varicose veins* - Hemorrhoids*
Directions:
(adults/children) Dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a physician.
Use:
Condition listed above or as directed by a physician.
Condition listed above or as directed by a physician.
Warnings:
Stop use and ask a physician if symptoms persist for more than 3 days or worsen.
Otc - Pregnancy Or Breast Feeding
If pregnant or breast-feeding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children.
Other Information:
Store at room temperature.
Otc - Do Not Use
Do not use if pellet-dispenser seal is broken.
Inactive Ingredient:
Sucrose.
Questions?
[email protected] * www.ollois.com * MADE IN FRANCE. NOT REVIEWED BY THE FDA AND NOT GUARANTEED TO BE EFFECTIVE. THIS HOMEOPATHIC DILUTION MAY NOT BE SUSEPTIBLE TO SCIENTIFIC MEASUREMENT.
Package Label.Principal Display Panel
Hamamelis 200ck (Label Ollois Hamamelis 200ck Page1)
Hamamelis 200ck (Label Ollois Hamamelis 200ck Page2)
Hamemelis 200ck (Page3 Label Ollois Common)
* Please review the disclaimer below.
